18
Participants
Start Date
August 31, 2009
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2015
PEMF
ActiPatch will be worn by patients over the eye with anterior uveitis for 8 hours/day for 7 days. Patients will also be treated with topical steroids.
PEMF Placebo
Patients wear the placebo device for 8 hours/day for 7 days over the eye being treated for anterior uveitis. Patients will also be treated with topical steroids.
Massachusetts Eye and Ear Infirmary, Boston
Collaborators (1)
BioElectronics Corporation
INDUSTRY
Massachusetts Eye and Ear Infirmary
OTHER